CA2513184A1 - Essai de detection de substrat - Google Patents

Essai de detection de substrat Download PDF

Info

Publication number: CA2513184A1
Authority: CA; Canada
Prior art keywords: nicotinamide; sample; activity; detecting; donor substrate
Prior art date: 2003-01-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002513184A

Other languages

English (en)

Inventor

Andrew Napper

Jeffrey Hixon

Tom Mcdonagh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Elixir Pharmaceuticals Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-16

Filing date

2004-01-16

Publication date

2004-08-05

2004-01-16 Application filed by Individual filed Critical Individual

2004-08-05 Publication of CA2513184A1 publication Critical patent/CA2513184A1/fr

Status Abandoned legal-status Critical Current

Links

239000000758 substrate Substances 0.000 title claims description 64
238000003556 assay Methods 0.000 title claims description 48
238000001514 detection method Methods 0.000 title claims description 11
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 230
238000000034 method Methods 0.000 claims abstract description 140
239000011570 nicotinamide Substances 0.000 claims abstract description 119
229960003966 nicotinamide Drugs 0.000 claims abstract description 119
235000005152 nicotinamide Nutrition 0.000 claims abstract description 108
230000003578 releasing effect Effects 0.000 claims abstract description 40
125000005621 boronate group Chemical group 0.000 claims abstract description 7
239000000523 sample Substances 0.000 claims description 95
230000000694 effects Effects 0.000 claims description 75
150000001875 compounds Chemical class 0.000 claims description 73
108090000765 processed proteins & peptides Proteins 0.000 claims description 63
102000004190 Enzymes Human genes 0.000 claims description 50
108090000790 Enzymes Proteins 0.000 claims description 50
108050002485 Sirtuin Proteins 0.000 claims description 47
102000011990 Sirtuin Human genes 0.000 claims description 47
239000011159 matrix material Substances 0.000 claims description 47
102000004196 processed proteins & peptides Human genes 0.000 claims description 42
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical group NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 41
229920001184 polypeptide Polymers 0.000 claims description 34
238000012360 testing method Methods 0.000 claims description 31
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 28
238000006243 chemical reaction Methods 0.000 claims description 20
239000000047 product Substances 0.000 claims description 19
239000011541 reaction mixture Substances 0.000 claims description 15
229910021529 ammonia Inorganic materials 0.000 claims description 14
230000027455 binding Effects 0.000 claims description 13
KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 12
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 11
108010019703 Nicotinamidase Proteins 0.000 claims description 8
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 8
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 7
239000004472 Lysine Substances 0.000 claims description 7
108010088865 Nicotinamide N-Methyltransferase Proteins 0.000 claims description 7
102000009063 Nicotinamide N-methyltransferase Human genes 0.000 claims description 7
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
239000013068 control sample Substances 0.000 claims description 6
235000019253 formic acid Nutrition 0.000 claims description 6
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 6
102000003964 Histone deacetylase Human genes 0.000 claims description 5
108090000353 Histone deacetylase Proteins 0.000 claims description 5
238000003381 deacetylation reaction Methods 0.000 claims description 5
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims description 5
230000002285 radioactive effect Effects 0.000 claims description 5
102000004157 Hydrolases Human genes 0.000 claims description 4
108090000604 Hydrolases Proteins 0.000 claims description 4
239000006227 byproduct Substances 0.000 claims description 4
230000006196 deacetylation Effects 0.000 claims description 4
150000000180 1,2-diols Chemical class 0.000 claims description 3
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 3
238000010438 heat treatment Methods 0.000 claims description 3
150000005480 nicotinamides Chemical class 0.000 claims description 3
230000003287 optical effect Effects 0.000 claims description 3
238000004611 spectroscopical analysis Methods 0.000 claims description 3
238000005119 centrifugation Methods 0.000 claims description 2
230000005484 gravity Effects 0.000 claims description 2
238000004128 high performance liquid chromatography Methods 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims 2
239000011347 resin Substances 0.000 abstract description 30
229920005989 resin Polymers 0.000 abstract description 30
239000000126 substance Substances 0.000 abstract description 27
239000000203 mixture Substances 0.000 abstract description 3
108090000623 proteins and genes Proteins 0.000 description 88
102000004169 proteins and genes Human genes 0.000 description 84
235000018102 proteins Nutrition 0.000 description 79
229950006238 nadide Drugs 0.000 description 53
150000007523 nucleic acids Chemical class 0.000 description 36
102000039446 nucleic acids Human genes 0.000 description 31
108020004707 nucleic acids Proteins 0.000 description 31
235000001014 amino acid Nutrition 0.000 description 24
150000001413 amino acids Chemical class 0.000 description 23
229940024606 amino acid Drugs 0.000 description 22
241000282414 Homo sapiens Species 0.000 description 18
125000000539 amino acid group Chemical group 0.000 description 15
230000033228 biological regulation Effects 0.000 description 15
-1 hydride ion Chemical class 0.000 description 15
230000013011 mating Effects 0.000 description 15
125000003275 alpha amino acid group Chemical group 0.000 description 12
ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 12
125000003729 nucleotide group Chemical group 0.000 description 11
210000004027 cell Anatomy 0.000 description 10
239000000284 extract Substances 0.000 description 10
239000002773 nucleotide Substances 0.000 description 10
108010033040 Histones Proteins 0.000 description 9
230000003993 interaction Effects 0.000 description 9
125000004356 hydroxy functional group Chemical group O* 0.000 description 8
239000006228 supernatant Substances 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 7
230000002255 enzymatic effect Effects 0.000 description 7
239000012634 fragment Substances 0.000 description 7
235000018977 lysine Nutrition 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
238000006467 substitution reaction Methods 0.000 description 7
108020004414 DNA Proteins 0.000 description 6
101000654471 Mus musculus NAD-dependent protein deacetylase sirtuin-1 Proteins 0.000 description 6
102100031455 NAD-dependent protein deacetylase sirtuin-1 Human genes 0.000 description 6
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
108010041191 Sirtuin 1 Proteins 0.000 description 6
239000002253 acid Substances 0.000 description 6
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
230000001413 cellular effect Effects 0.000 description 6
238000013461 design Methods 0.000 description 6
229930003944 flavone Natural products 0.000 description 6
235000011949 flavones Nutrition 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
102000010084 Group III Histone Deacetylases Human genes 0.000 description 5
108010077337 Group III Histone Deacetylases Proteins 0.000 description 5
BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 5
108091023040 Transcription factor Proteins 0.000 description 5
102000040945 Transcription factor Human genes 0.000 description 5
239000000370 acceptor Substances 0.000 description 5
229910052921 ammonium sulfate Inorganic materials 0.000 description 5
235000011130 ammonium sulphate Nutrition 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
239000000706 filtrate Substances 0.000 description 5
150000002212 flavone derivatives Chemical class 0.000 description 5
230000000051 modifying effect Effects 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
238000000746 purification Methods 0.000 description 5
PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
QHYWQIVTVQAKQF-UHFFFAOYSA-N 3,5-dihydroxy-2-phenylchromen-4-one Chemical compound OC=1C(=O)C=2C(O)=CC=CC=2OC=1C1=CC=CC=C1 QHYWQIVTVQAKQF-UHFFFAOYSA-N 0.000 description 4
DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 4
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 4
102000006947 Histones Human genes 0.000 description 4
108010021466 Mutant Proteins Proteins 0.000 description 4
102000008300 Mutant Proteins Human genes 0.000 description 4
102100030710 NAD-dependent protein deacetylase sirtuin-3, mitochondrial Human genes 0.000 description 4
108010043958 Peptoids Proteins 0.000 description 4
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
102000004357 Transferases Human genes 0.000 description 4
108090000992 Transferases Proteins 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 4
239000011324 bead Substances 0.000 description 4
230000004071 biological effect Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
235000005513 chalcones Nutrition 0.000 description 4
238000010586 diagram Methods 0.000 description 4
239000003814 drug Substances 0.000 description 4
238000006911 enzymatic reaction Methods 0.000 description 4
238000001914 filtration Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
239000002243 precursor Substances 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
238000003345 scintillation counting Methods 0.000 description 4
238000000926 separation method Methods 0.000 description 4
GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
239000005695 Ammonium acetate Substances 0.000 description 3
ZYVXHFWBYUDDBM-UHFFFAOYSA-N N-methylnicotinamide Chemical compound CNC(=O)C1=CC=CN=C1 ZYVXHFWBYUDDBM-UHFFFAOYSA-N 0.000 description 3
108010067902 Peptide Library Proteins 0.000 description 3
108091093037 Peptide nucleic acid Proteins 0.000 description 3
241000700157 Rattus norvegicus Species 0.000 description 3
102000000477 Sirtuin 2 Human genes 0.000 description 3
108010041216 Sirtuin 2 Proteins 0.000 description 3
108010041218 Sirtuin 3 Proteins 0.000 description 3
GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
235000019257 ammonium acetate Nutrition 0.000 description 3
229940043376 ammonium acetate Drugs 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
229940049706 benzodiazepine Drugs 0.000 description 3
150000001557 benzodiazepines Chemical class 0.000 description 3
230000004663 cell proliferation Effects 0.000 description 3
125000003636 chemical group Chemical group 0.000 description 3
229940079593 drug Drugs 0.000 description 3
150000002213 flavones Chemical class 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
230000009878 intermolecular interaction Effects 0.000 description 3
DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 3
150000002611 lead compounds Chemical class 0.000 description 3
239000003446 ligand Substances 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
229960003512 nicotinic acid Drugs 0.000 description 3
235000001968 nicotinic acid Nutrition 0.000 description 3
239000011664 nicotinic acid Substances 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
238000005556 structure-activity relationship Methods 0.000 description 3
125000001424 substituent group Chemical group 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 3
VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
VHMZOJZWCDPECI-UHFFFAOYSA-N 1-phenyl-3-(2,3,4,5-tetrahydroxyphenyl)prop-2-en-1-one Chemical compound OC1=C(O)C(O)=CC(C=CC(=O)C=2C=CC=CC=2)=C1O VHMZOJZWCDPECI-UHFFFAOYSA-N 0.000 description 2
BFNOPXRXIQJDHO-YDKGJHSESA-N 2''-O-acetyl-ADP-D-ribose Chemical compound O[C@H]1[C@@H](OC(=O)C)C(O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=NC=NC(N)=C3N=C2)O1 BFNOPXRXIQJDHO-YDKGJHSESA-N 0.000 description 2
ZZLQHXCRRMUGQJ-UHFFFAOYSA-N 2'-Hydroxyflavone Natural products OC1=CC=CC=C1C1=CC(=O)C2=CC=CC=C2O1 ZZLQHXCRRMUGQJ-UHFFFAOYSA-N 0.000 description 2
VFGLRVWAOAFUGZ-UHFFFAOYSA-N 2,3-dihydroxy-1,3-diphenylprop-2-en-1-one Chemical compound C=1C=CC=CC=1C(=O)C(O)=C(O)C1=CC=CC=C1 VFGLRVWAOAFUGZ-UHFFFAOYSA-N 0.000 description 2
VENIESHBHYOFBE-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one 3,5,6,7,8-pentahydroxy-2-phenylchromen-4-one Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1.OC=1C(O)=C(O)C(O)=C(C(C=2O)=O)C=1OC=2C1=CC=CC=C1 VENIESHBHYOFBE-UHFFFAOYSA-N 0.000 description 2
QLHSZVGLSUHUOI-UHFFFAOYSA-N 3,5,6-trihydroxy-2-phenylchromen-4-one Chemical compound OC=1C(=O)C2=C(O)C(O)=CC=C2OC=1C1=CC=CC=C1 QLHSZVGLSUHUOI-UHFFFAOYSA-N 0.000 description 2
UDOOPSJCRMKSGL-UHFFFAOYSA-N 3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one Chemical compound OC1=CC=CC=C1C=CC(=O)C1=CC=CC=C1 UDOOPSJCRMKSGL-UHFFFAOYSA-N 0.000 description 2
102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 2
108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
206010008631 Cholera Diseases 0.000 description 2
102000018832 Cytochromes Human genes 0.000 description 2
108010052832 Cytochromes Proteins 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
YIKKXFLEUOHLMO-UHFFFAOYSA-N OC1=C(OC2=CC(=CC=C2C1=O)O)C1=CC(=C(C=C1)O)O.OC1=C(C(=C2C(C(=C(OC2=C1)C1=CC=CC=C1)O)=O)O)O Chemical compound OC1=C(OC2=CC(=CC=C2C1=O)O)C1=CC(=C(C=C1)O)O.OC1=C(C(=C2C(C(=C(OC2=C1)C1=CC=CC=C1)O)=O)O)O YIKKXFLEUOHLMO-UHFFFAOYSA-N 0.000 description 2
201000005702 Pertussis Diseases 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
238000013459 approach Methods 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
125000004429 atom Chemical group 0.000 description 2
230000008901 benefit Effects 0.000 description 2
229910021538 borax Inorganic materials 0.000 description 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
150000001788 chalcone derivatives Chemical class 0.000 description 2
239000012707 chemical precursor Substances 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
210000004748 cultured cell Anatomy 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
206010013023 diphtheria Diseases 0.000 description 2
238000001952 enzyme assay Methods 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Chemical compound O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
238000007421 fluorometric assay Methods 0.000 description 2
230000005714 functional activity Effects 0.000 description 2
125000001475 halogen functional group Chemical group 0.000 description 2
125000001072 heteroaryl group Chemical group 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
210000003000 inclusion body Anatomy 0.000 description 2
230000006698 induction Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
150000002484 inorganic compounds Chemical class 0.000 description 2
229910010272 inorganic material Inorganic materials 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
DXDRHHKMWQZJHT-UHFFFAOYSA-N isoliquiritigenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-UHFFFAOYSA-N 0.000 description 2
125000005647 linker group Chemical group 0.000 description 2
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
239000000463 material Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Chemical compound CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000000816 peptidomimetic Substances 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
239000012857 radioactive material Substances 0.000 description 2
239000000376 reactant Substances 0.000 description 2
238000011160 research Methods 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
238000012216 screening Methods 0.000 description 2
230000009758 senescence Effects 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
235000010265 sodium sulphite Nutrition 0.000 description 2
235000010339 sodium tetraborate Nutrition 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
235000021286 stilbenes Nutrition 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
238000012546 transfer Methods 0.000 description 2
BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
239000004474 valine Substances 0.000 description 2
239000013598 vector Substances 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 1
PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 1
JRYYVMDEUJQWRO-UHFFFAOYSA-N 2-methylnicotinamide Chemical compound CC1=NC=CC=C1C(N)=O JRYYVMDEUJQWRO-UHFFFAOYSA-N 0.000 description 1
KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 1
230000005730 ADP ribosylation Effects 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
231100000699 Bacterial toxin Toxicity 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
101150056840 CAD9 gene Proteins 0.000 description 1
101100002344 Caenorhabditis elegans arid-1 gene Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
241000727928 Cissus incisa Species 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
BQOHYSXSASDCEA-KEOHHSTQSA-N Cyclic ADP-Ribose Chemical compound C([C@@H]1[C@H]([C@H]([C@@H](O1)N1C=2N=CN3C(C=2N=C1)=N)O)O)OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H]3O1 BQOHYSXSASDCEA-KEOHHSTQSA-N 0.000 description 1
101800000778 Cytochrome b-c1 complex subunit 9 Proteins 0.000 description 1
102400000011 Cytochrome b-c1 complex subunit 9 Human genes 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
102000016607 Diphtheria Toxin Human genes 0.000 description 1
108010053187 Diphtheria Toxin Proteins 0.000 description 1
101000702533 Drosophila melanogaster NAD-dependent protein deacetylase Sirt2 Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
102100039869 Histone H2B type F-S Human genes 0.000 description 1
101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 1
101001122938 Homo sapiens Lysosomal protective protein Proteins 0.000 description 1
101000963759 Homo sapiens Melanocortin-2 receptor accessory protein Proteins 0.000 description 1
101000709248 Homo sapiens NAD-dependent protein deacetylase sirtuin-7 Proteins 0.000 description 1
101000616727 Homo sapiens NAD-dependent protein deacylase sirtuin-5, mitochondrial Proteins 0.000 description 1
101000863629 Homo sapiens NAD-dependent protein lipoamidase sirtuin-4, mitochondrial Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102100028524 Lysosomal protective protein Human genes 0.000 description 1
102100040147 Melanocortin-2 receptor accessory protein Human genes 0.000 description 1
102000006404 Mitochondrial Proteins Human genes 0.000 description 1
108010058682 Mitochondrial Proteins Proteins 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
DTERQYGMUDWYAZ-ZETCQYMHSA-N N(6)-acetyl-L-lysine Chemical compound CC(=O)NCCCC[C@H]([NH3+])C([O-])=O DTERQYGMUDWYAZ-ZETCQYMHSA-N 0.000 description 1
102000002250 NAD+ Nucleosidase Human genes 0.000 description 1
108010000193 NAD+ Nucleosidase Proteins 0.000 description 1
102100034376 NAD-dependent protein deacetylase sirtuin-7 Human genes 0.000 description 1
102100021839 NAD-dependent protein deacylase sirtuin-5, mitochondrial Human genes 0.000 description 1
102100030709 NAD-dependent protein lipoamidase sirtuin-4, mitochondrial Human genes 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
108091005461 Nucleic proteins Chemical group 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
102000012338 Poly(ADP-ribose) Polymerases Human genes 0.000 description 1
108010061844 Poly(ADP-ribose) Polymerases Proteins 0.000 description 1
108091026813 Poly(ADPribose) Proteins 0.000 description 1
229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
235000014443 Pyrus communis Nutrition 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
108091005770 SIRT3 Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
101710201756 T-cell ecto-ADP-ribosyltransferase 1 Proteins 0.000 description 1
101710201751 T-cell ecto-ADP-ribosyltransferase 2 Proteins 0.000 description 1
244000156473 Vallaris heynei Species 0.000 description 1
239000008351 acetate buffer Substances 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000012190 activator Substances 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
230000032683 aging Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000000688 bacterial toxin Substances 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000000872 buffer Substances 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
238000000423 cell based assay Methods 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
150000001789 chalcones Chemical class 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
235000019365 chlortetracycline Nutrition 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
238000013375 chromatographic separation Methods 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
239000007859 condensation product Substances 0.000 description 1
125000004093 cyano group Chemical group *C#N 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
230000000850 deacetylating effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000001212 derivatisation Methods 0.000 description 1
238000011026 diafiltration Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
239000012636 effector Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000007824 enzymatic assay Methods 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
230000006197 histone deacetylation Effects 0.000 description 1
150000001469 hydantoins Chemical class 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000002609 medium Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
238000002156 mixing Methods 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
230000035772 mutation Effects 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
108091008104 nucleic acid aptamers Proteins 0.000 description 1
238000005457 optimization Methods 0.000 description 1
150000002902 organometallic compounds Chemical class 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
238000002823 phage display Methods 0.000 description 1
239000012071 phase Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000008569 process Effects 0.000 description 1
238000003498 protein array Methods 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
150000003222 pyridines Chemical class 0.000 description 1
150000003235 pyrrolidines Chemical class 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000028617 response to DNA damage stimulus Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
239000002342 ribonucleoside Substances 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
238000006798 ring closing metathesis reaction Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000006104 solid solution Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
241000894007 species Species 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
150000001629 stilbenes Chemical class 0.000 description 1
102000055501 telomere Human genes 0.000 description 1
108091035539 telomere Proteins 0.000 description 1
210000003411 telomere Anatomy 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
- G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Analytical Chemistry (AREA)
Wood Science & Technology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA002513184A 2003-01-16 2004-01-16 Essai de detection de substrat Abandoned CA2513184A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US44072303P	2003-01-16	2003-01-16
US60/440,723		2003-01-16
PCT/US2004/001239 WO2004064739A2 (fr)	2003-01-16	2004-01-16	Essai de detection de substrat

Publications (1)

Publication Number	Publication Date
CA2513184A1 true CA2513184A1 (fr)	2004-08-05

Family

ID=32771853

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002513184A Abandoned CA2513184A1 (fr)	2003-01-16	2004-01-16	Essai de detection de substrat

Country Status (4)

Country	Link
EP (1)	EP1587951A4 (fr)
AU (1)	AU2004206887A1 (fr)
CA (1)	CA2513184A1 (fr)
WO (1)	WO2004064739A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005038043A2 (fr) *	2003-10-14	2005-04-28	The Board Of Trustees Of The University Of Illinois	Methodes de detection de la poly(adp-ribose) polymerase et d'autres enzymes faisant appel a nad+
WO2008100376A2 (fr) *	2007-02-15	2008-08-21	Sirtris Pharmaceuticals, Inc.	Variants de troncature de sirt1 et procédés d'utilisation de ceux-ci
EP2446048A4 (fr) *	2009-06-23	2013-04-03	Harvard College	Méthodes et kits de mesure de l 'activité enzymatique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4704365A (en) *	1986-02-24	1987-11-03	Abbott Laboratories	Composition and method for stabilization of dinucleotides

2004
- 2004-01-16 EP EP04703016A patent/EP1587951A4/fr not_active Withdrawn
- 2004-01-16 AU AU2004206887A patent/AU2004206887A1/en not_active Abandoned
- 2004-01-16 WO PCT/US2004/001239 patent/WO2004064739A2/fr not_active Ceased
- 2004-01-16 CA CA002513184A patent/CA2513184A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
WO2004064739A3 (fr)	2005-04-21
EP1587951A4 (fr)	2007-04-25
EP1587951A2 (fr)	2005-10-26
WO2004064739A2 (fr)	2004-08-05
AU2004206887A1 (en)	2004-08-05

Publication	Publication Date	Title
Eisenthal et al.	2002	Enzyme assays: a practical approach
Cashel	1969	The control of ribonucleic acid synthesis in Escherichia coli: IV. Relevance of unusual phosphorylated compounds from amino acid-starved stringent strains
Weber et al.	2012	Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells
Gillespie et al.	1999	Engineering of the myosin-Iβ nucleotide-binding pocket to create selective sensitivity to N 6-modified ADP analogs
Mishanina et al.	2012	Trapping of an intermediate in the reaction catalyzed by flavin-dependent thymidylate synthase
Dalvit et al.	2020	Fluorine NMR functional screening: from purified enzymes to human intact living cells
Swinehart et al.	2020	Specificity in the biosynthesis of the universal tRNA nucleoside N6-threonylcarbamoyl adenosine (t6A)—TsaD is the gatekeeper
Dervieux et al.	2002	HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy
Shoup et al.	1980	Determination of catechol-O-methyltransferase activity in various tissues by liquid chromatography
Zhang et al.	2020	A simplified thermal proteome profiling approach to screen protein targets of a ligand
Hussain et al.	1985	Radioenzymatic microassay for simultaneous estimations of dopamine, norepinephrine, and epinephrine in plasma, urine, and tissues.
Holt et al.	2009	Label-free high-throughput screening via mass spectrometry: a single cystathionine quantitative method for multiple applications
Šebela	2023	The use of matrix‐assisted laser desorption/ionization mass spectrometry in enzyme activity assays and its position in the context of other available methods
Lee et al.	2018	Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase1 (NTPDase1, CD39)
CA2513184A1 (fr)	2004-08-05	Essai de detection de substrat
do Amaral et al.	2021	Phosphoenolpyruvate carboxykinase from T. cruzi magnetic beads affinity-based screening assays on crude plant extracts from Brazilian Cerrado
Chimploy et al.	2013	Ribonucleotide reductase association with mammalian liver mitochondria
Wolff et al.	2011	Assay of deoxyhypusine synthase activity
Yu et al.	2015	A [32P] NAD+-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors
Goldberg et al.	1971	Analysis of cyclic 3′, 5′‐adenosine monophosphate and cyclic 3′, 5′‐guanosine monophosphate
US6046017A (en)	2000-04-04	Rapid and sensitive assay for homocysteine
US20060292652A1 (en)	2006-12-28	Substrate detection assay
JP5462427B2 (ja)	2014-04-02	生物学的流体のアッセイ方法
CA2519361A1 (fr)	2004-10-07	Methode criblage de ligands cibles
Otterness et al.	1986	Mouse liver thiol methyltransferase. Assay conditions, biochemical properties, and strain variation.

Legal Events

Date	Code	Title	Description
2008-01-16	FZDE	Discontinued